Skip to content

Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection

Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03121144
Enrollment
34
Registered
2017-04-19
Start date
2017-03-01
Completion date
2019-03-27
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Falls Injury, Pressure Injury, Pressure Ulcer

Brief summary

This study describes a procedure to collect a subject's position, movement, physiological data and usability information using Masimo's investigational device.

Interventions

DEVICEMasimo Centroid System

Noninvasive positional monitoring device

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. At least 18 years of age 2. ICU patient 3. Primarily bedbound subjects 4. Able to be monitored for a minimum of approximately 8 hours

Exclusion criteria

1. Pregnancy 2. Prisoner status 3. Pressure injury stage 2, 3, or ungroupable 4. Has a pacemaker or internal defibrillator 5. Has a history of complications with a similar study 6. Has any medical condition which in the judgment of the Investigator, renders them inappropriate for participation in this study

Design outcomes

Primary

MeasureTime frameDescription
Usability Validation of Masimo Centroid SystemAt least 8 hoursThe number of participants enrolled to assess the usability of the Masimo Centroid System.

Countries

United States

Participant flow

Participants by arm

ArmCount
Masimo Centroid System
All subjects are enrolled into the test group wherein the noninvasive positional monitoring device will be administered.
34
Total34

Baseline characteristics

CharacteristicMasimo Centroid System
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
8 Participants
Age, Categorical
Between 18 and 65 years
26 Participants
Race/Ethnicity, Customized
African American
14 Participants
Race/Ethnicity, Customized
Asian
2 Participants
Race/Ethnicity, Customized
Asian/Native Hawaiian
1 Participants
Race/Ethnicity, Customized
White
17 Participants
Region of Enrollment
United States
34 participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 34
other
Total, other adverse events
0 / 34
serious
Total, serious adverse events
0 / 34

Outcome results

Primary

Usability Validation of Masimo Centroid System

The number of participants enrolled to assess the usability of the Masimo Centroid System.

Time frame: At least 8 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Masimo Centroid SystemUsability Validation of Masimo Centroid System34 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026